Cargando…
Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses
The highest density of microbes resides in human gastrointestinal tract, known as “Gut microbiome”. Of note, the members of the genus Lactobacillus that belong to phyla Firmicutes are the most important probiotic bacteria of the gut microbiome. These gut-residing Lactobacillus species not only commu...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638459/ https://www.ncbi.nlm.nih.gov/pubmed/36353491 http://dx.doi.org/10.3389/fphar.2022.1042189 |
_version_ | 1784825419856347136 |
---|---|
author | Rastogi, Sonakshi Singh, Aditi |
author_facet | Rastogi, Sonakshi Singh, Aditi |
author_sort | Rastogi, Sonakshi |
collection | PubMed |
description | The highest density of microbes resides in human gastrointestinal tract, known as “Gut microbiome”. Of note, the members of the genus Lactobacillus that belong to phyla Firmicutes are the most important probiotic bacteria of the gut microbiome. These gut-residing Lactobacillus species not only communicate with each other but also with the gut epithelial lining to balance the gut barrier integrity, mucosal barrier defence and ameliorate the host immune responses. The human body suffers from several inflammatory diseases affecting the gut, lungs, heart, bone or neural tissues. Mounting evidence supports the significant role of Lactobacillus spp. and their components (such as metabolites, peptidoglycans, and/or surface proteins) in modulatingimmune responses, primarily through exchange of immunological signals between gastrointestinal tract and distant organs. This bidirectional crosstalk which is mediated by Lactobacillus spp. promotes anti-inflammatory response, thereby supporting the improvement of symptoms pertaining to asthma, chronic obstructive pulmonary disease (COPD), neuroinflammatory diseases (such as multiple sclerosis, alzheimer’s disease, parkinson’s disease), cardiovascular diseases, inflammatory bowel disease (IBD) and chronic infections in patients. The metabolic disorders, obesity and diabetes are characterized by a low-grade inflammation. Genus Lactobacillus alleviates metabolic disorders by regulating the oxidative stress response and inflammatory pathways. Osteoporosis is also associated with bone inflammation and resorption. The Lactobacillus spp. and their metabolites act as powerful immune cell controllers and exhibit a regulatory role in bone resorption and formation, supporting bone health. Thus, this review demonstrated the mechanisms and summarized the evidence of the benefit of Lactobacillus spp. in alleviating inflammatory diseases pertaining to different organs from animal and clinical trials. The present narrative review explores in detail the complex interactions between the gut-dwelling Lactobacillus spp. and the immune components in distant organs to promote host’s health. |
format | Online Article Text |
id | pubmed-9638459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96384592022-11-08 Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses Rastogi, Sonakshi Singh, Aditi Front Pharmacol Pharmacology The highest density of microbes resides in human gastrointestinal tract, known as “Gut microbiome”. Of note, the members of the genus Lactobacillus that belong to phyla Firmicutes are the most important probiotic bacteria of the gut microbiome. These gut-residing Lactobacillus species not only communicate with each other but also with the gut epithelial lining to balance the gut barrier integrity, mucosal barrier defence and ameliorate the host immune responses. The human body suffers from several inflammatory diseases affecting the gut, lungs, heart, bone or neural tissues. Mounting evidence supports the significant role of Lactobacillus spp. and their components (such as metabolites, peptidoglycans, and/or surface proteins) in modulatingimmune responses, primarily through exchange of immunological signals between gastrointestinal tract and distant organs. This bidirectional crosstalk which is mediated by Lactobacillus spp. promotes anti-inflammatory response, thereby supporting the improvement of symptoms pertaining to asthma, chronic obstructive pulmonary disease (COPD), neuroinflammatory diseases (such as multiple sclerosis, alzheimer’s disease, parkinson’s disease), cardiovascular diseases, inflammatory bowel disease (IBD) and chronic infections in patients. The metabolic disorders, obesity and diabetes are characterized by a low-grade inflammation. Genus Lactobacillus alleviates metabolic disorders by regulating the oxidative stress response and inflammatory pathways. Osteoporosis is also associated with bone inflammation and resorption. The Lactobacillus spp. and their metabolites act as powerful immune cell controllers and exhibit a regulatory role in bone resorption and formation, supporting bone health. Thus, this review demonstrated the mechanisms and summarized the evidence of the benefit of Lactobacillus spp. in alleviating inflammatory diseases pertaining to different organs from animal and clinical trials. The present narrative review explores in detail the complex interactions between the gut-dwelling Lactobacillus spp. and the immune components in distant organs to promote host’s health. Frontiers Media S.A. 2022-10-24 /pmc/articles/PMC9638459/ /pubmed/36353491 http://dx.doi.org/10.3389/fphar.2022.1042189 Text en Copyright © 2022 Rastogi and Singh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Rastogi, Sonakshi Singh, Aditi Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title | Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title_full | Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title_fullStr | Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title_full_unstemmed | Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title_short | Gut microbiome and human health: Exploring how the probiotic genus Lactobacillus modulate immune responses |
title_sort | gut microbiome and human health: exploring how the probiotic genus lactobacillus modulate immune responses |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638459/ https://www.ncbi.nlm.nih.gov/pubmed/36353491 http://dx.doi.org/10.3389/fphar.2022.1042189 |
work_keys_str_mv | AT rastogisonakshi gutmicrobiomeandhumanhealthexploringhowtheprobioticgenuslactobacillusmodulateimmuneresponses AT singhaditi gutmicrobiomeandhumanhealthexploringhowtheprobioticgenuslactobacillusmodulateimmuneresponses |